Evaluation of the Teen Outreach Program in Chicago Public Schools

Evaluation of the Teen Outreach Program in Chicago Public Schools: Replication of an Evidence-Based Teen Pregnancy Prevention Program

The purpose of this study was to determine the impact of TOP® on sexual health behavior.

Study Overview

• Status: Completed
• Conditions: Sexual Behavior
• Intervention / Treatment: Behavioral: Teen Outreach Program

Detailed Description

The cluster-randomized study was conducted in 9th grade classrooms in Chicago Public Schools (CPS) with equal number of schools randomized to intervention and comparison groups for two cohort years. Students were administered a scannable paper survey at three time points: baseline, post-program and 1-year post program. The primary impact analysis used an intent-to-treat approach. Implementation of TOP® was assessed by conducting classroom observations. TOP® was delivered in a variety of classroom settings over the school year by facilitators from CPS and partner organizations.

• Study Type: Interventional
• Enrollment (Actual): 12253
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 12 years to 17 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• First-time 9th grade student
• Passive parental consent and student assent

Exclusion Criteria:

• Inability to complete survey in languages provided

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Teen Outreach Program	Behavioral: Teen Outreach Program; TOP® is a positive youth development and service learning program for youth ages 12 to 17, and its Changing Scenes curriculum is separated into age appropriate levels. The program uses an approach that involves a caring adult, positive self-efficacy, future planning and goal setting and life management skills to to reduce risky sexual behavior and improve school outcomes. TOP® is designed to be delivered in weekly sessions over 9 months and includes community service learning.
No Intervention: Comparison; Business as usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sex without a condom in the last 90 days	Dichotomous indicator from self-report survey	9 months after baseline

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sex in the last 90 days	Dichotomous indicator from self-report survey	9 months after baseline
Sex without a condom in the last 90 days, by race/ethnicity	Dichotomous indicator from self-report survey	9 months after baseline
Sex without a condom in the last 90 days	Dichotomous indicator from self-report survey	21 months after baseline

Collaborators and Investigators

• Sponsor: Chapin Hall at the University of Chicago
• Collaborators: Chicago Public Schools

Publications and helpful links

General Publications

• Seshadri R, Smithgall C, Goerge R, Ippolito J, Dasgupta D, Wiegand E, Guiltinan S, Wood M. (2015) Evaluation of the Teen Outreach Program: Findings from the Replication of an Evidence-Based Teen Pregnancy Prevention Program. Chicago, IL: Chapin Hall at the University of Chicago

Study record dates

Study Major Dates

• Study Start: September 1, 2010
• Primary Completion (Actual): June 1, 2014
• Study Completion (Actual): August 1, 2015

Study Registration Dates

• First Submitted: September 10, 2015
• First Submitted That Met QC Criteria: September 11, 2015
• First Posted (Estimate): September 14, 2015

Study Record Updates

• Last Update Posted (Estimate): September 14, 2015
• Last Update Submitted That Met QC Criteria: September 11, 2015
• Last Verified: September 1, 2015

More Information

Terms related to this study

• Other Study ID Numbers: TP1AH000066

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No